The Effect of Spirulina Platensis on fasting blood Glucose, Glycosylated Hemoglobin (HbA1c) and Lipid Profile in Type 2 diabetic Patients. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: Patients enrolled in the study will be in control and intervention groups. In addition to conventional anti-diabetic treatment, the intervention group will receive
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Type 2 Diabetes Mellitus Fasting plasma glucoseis equal to or greater than 100 to 125 mg / dl The OGTT test equal to or greater than 140 to 199 mg / dl Hb1c: 4.6 to 7.5 Less than 5 years of treatment with anti-diabetes drugs
Exclusion criteria
Exclusion criteria: Not having diabetes Pregnancy and lactation Patients with phenylketonuria 36/5000Patients with autoimmune diseases Patients with kidney or liver failure Use of antioxidant supplements and vitamins (especially B vitamin groups)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the change in hemoglobin beta-glycosylated (HbA1c) levels. Timepoint: The timing is measured at the beginning of the study and the days 30, 60, and 90 of the study. Method of measurement: Chromatography will be used to measure HbA1c. | — |
Secondary
| Measure | Time frame |
|---|---|
| ?Fasting blood Glucoseand Lipid Profile. Timepoint: The timing is measured at the beginning of the study and the days 30, 60, and 90 of the study. Method of measurement: Blood glucose analysis and use of lipid profile kits. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZhila Taherzadeh
Mashhad University of Medical Sciences
Outcome results
None listed